Myasthenia gravis plasma exchange is used in the acute and critical phase of the treatment.
Myasthenia gravis plasma exchange is to remove the patient’s plasma and return an equal amount of normal plasma or replacement fluid to reduce the antibody of acetylcholine receptor on the myocytes at the neuromuscular junction, and the general volume of each exchange is 2000 ml, 1~3 times a week for 3~8 consecutive times.
Plasma exchange for myasthenia gravis can quickly relieve symptoms, but only lasts for 1 week to 2 months, as the antibody level increases the patient’s symptoms of myasthenia gravis will gradually appear, and because of the large amount of coagulation factors lost in the process of replacement, there may be bleeding and other complications.
Whether or not to use plasma replacement therapy for myasthenia gravis patients should follow the doctor’s instructions, under the guidance of a professional physician to determine according to the individual’s condition, do not make a blind decision on your own to avoid delays in the condition.